Macrophage migration inhibitory factor governs endothelial cell sensitivity to LPS-induced apoptosis

Rachel L Damico1, Alan Chesley, Laura Johnston

  • 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD 21224, USA.

Insights

Macrophage migration inhibitory factor (MIF) protects human pulmonary artery endothelial cells (HPAECs) from cell death. MIF regulates the FLICE-like inhibitory protein (FLIP), preventing apoptosis during inflammation.

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Human endothelial cells (ECs) exhibit resistance to apoptosis, a crucial factor in lung disease pathogenesis.
  • The molecular mechanisms underlying EC apoptosis resistance are not fully understood.
  • Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, is produced by ECs and its expression is upregulated by death-inducing stimuli like lipopolysaccharide (LPS).

Purpose of the Study:

  • To investigate the role of MIF in EC apoptosis resistance.
  • To elucidate the molecular pathway through which MIF confers protection against apoptosis.
  • To determine if MIF regulates the expression of apoptosis-related proteins like FLIP.

Main Methods:

  • Utilized RNA interference (siRNA) to silence MIF expression in human pulmonary artery ECs (HPAECs).
  • Assessed the impact of MIF silencing on HPAEC sensitivity to LPS-induced cell death.
  • Investigated the effect of recombinant human MIF (rhMIF) on cell survival and apoptosis.
  • Examined the regulation of FLICE-like inhibitory protein (FLIP) expression by MIF using Western blotting and siRNA.
  • Determined the position of MIF in the apoptotic pathway relative to FLIP.

Main Results:

  • Silencing MIF expression significantly sensitized HPAECs to LPS-induced apoptosis.
  • Addition of rhMIF reversed the cell death-sensitizing effect of MIF siRNA.
  • LPS induced an increase in the short isoform of FLIP (FLIP(s)), which was blocked by MIF siRNA but restored by rhMIF.
  • FLIP(s) siRNA also sensitized HPAECs to LPS-induced death, but rhMIF did not alter this sensitization.
  • These findings place MIF upstream of FLIP(s) in the pathway preventing HPAEC death.

Conclusions:

  • MIF acts as an endogenous pro-survival factor in HPAECs.
  • MIF protects vascular endothelial cells from inflammation-associated cell damage by regulating FLIP(s) expression.
  • This study identifies a novel mechanism of MIF-mediated apoptosis resistance in ECs.